Continuous infusion of simoctocog alfa in haemophilia A patients undergoing surgeries.

Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2018)

Continuous infusion with simoctocog alfa was found to achieve good/excellent haemostatic efficacy in all procedures. No adverse events occurred and no inhibitors developed.

Keyphrases

patients undergoing
low dose
replacement therapy
smoking cessation